OraSure Technologies Inc (OSUR)

Currency in USD
3.120
0.000(0.00%)
Closed·
After Hours
3.000-0.120(-3.85%)
·
OSUR Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected today
Fair Value
Day's Range
3.0603.160
52 wk Range
2.3604.920
Key Statistics
Prev. Close
3.12
Open
3.1
Day's Range
3.06-3.16
52 wk Range
2.36-4.92
Volume
404.73K
Average Volume (3m)
762.76K
1-Year Change
-27.78%
Book Value / Share
5.3
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OSUR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.000
Upside
+92.31%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

OraSure Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

OraSure Technologies Inc Company Profile

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally. The company’s products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, and OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; and Colli-Pee collection devices for the volumetric collection of void urine samples. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, the company develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.

OraSure Technologies Inc Earnings Call Summary for Q2/2025

  • Q2 revenue of $31.24M beat forecast, but EPS of -$0.19 missed; stock unchanged at $3.12 in aftermarket trading
  • GAAP operating loss of $18M; non-GAAP loss of $13.2M; strong cash position of $235M with no debt
  • Q3 revenue guidance of $27-30M; CEO expects return to growth in 2026 driven by new product launches
  • Ongoing challenges: operating losses, uncertain public health funding, international market disruptions
  • Analysts anticipate 32% revenue decline for current year; focus on innovation with $10M planned for Q3
Last Updated: 05/08/2025, 23:40
Read Full Transcript

Compare OSUR to Peers and Sector

Metrics to compare
OSUR
Peers
Sector
Relationship
P/E Ratio
−7.3x−11.1x−0.5x
PEG Ratio
0.03−0.280.00
Price/Book
0.6x2.5x2.6x
Price / LTM Sales
1.4x3.7x3.3x
Upside (Analyst Target)
92.3%76.1%43.5%
Fair Value Upside
Unlock1.6%6.3%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.000
(+92.31% Upside)

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
-0.19 / -0.17
Revenue / Forecast
31.24M / 30.52M
EPS Revisions
Last 90 days

OSUR Income Statement

People Also Watch

37.46
EXEL
+1.77%
16.47
ARWR
+0.03%
237.47
POWL
+3.17%
36.14
CYTK
-1.20%
57.74
TEM
+0.38%

FAQ

What Stock Exchange Does OraSure Trade On?

OraSure is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for OraSure?

The stock symbol for OraSure is "OSUR."

What Is the OraSure Market Cap?

As of today, OraSure market cap is 232.63M.

What Is OraSure's Earnings Per Share (TTM)?

The OraSure EPS (TTM) is -0.43.

When Is the Next OraSure Earnings Date?

OraSure will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is OSUR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has OraSure Stock Split?

OraSure has split 1 times.

How Many Employees Does OraSure Have?

OraSure has 501 employees.

What is the current trading status of OraSure (OSUR)?

As of 05 Aug 2025, OraSure (OSUR) is trading at a price of 3.12, with a previous close of 3.12. The stock has fluctuated within a day range of 3.06 to 3.16, while its 52-week range spans from 2.36 to 4.92.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.